お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、獣医用ワクチンの世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に獣医用ワクチン市場を分類しています。
本レポートでは世界の獣医用ワクチン市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Merck、Zoetis、Boehringer Ingelheim、Ceva、CAHIC、HVRI、Ringpu Biology、Yebio、DHN、WINSUN、Elanco、Virbac、Jinyu Bio-Technology、Medion、CAVAC、Kyoto Biken Laboratories、FATRO、Vaksindo、Bio-Labs、Avimex Animal Health、MEVAC、Biovac、Atafen、Dyntec、RVSRI

レポートは獣医用ワクチンの主要生産者を調査し、主要地域や国の消費状況も提供します。獣医用ワクチンの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Live Attenuated Vaccines
    Inactivated Vaccines
    Other

用途別の市場セグメント：
    Farm Animal
    Companion Animal

本レポートの詳細内容
本レポートは、世界の獣医用ワクチン市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて獣医用ワクチン市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）の獣医用ワクチン生産量、成長率、市場シェアを調査している。

二. 消費面では、獣医用ワクチンの売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーの獣医用ワクチン売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の獣医用ワクチン市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本獣医用ワクチンのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：獣医用ワクチンのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： 獣医用ワクチンの世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおける獣医用ワクチンの売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章獣医用ワクチンメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：獣医用ワクチンの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：獣医用ワクチンの主要メーカーの概要を提供し、製品の説明と仕様、獣医用ワクチンの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：獣医用ワクチンの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
The global Veterinary Vaccine market is projected to grow from US$ 12390 million in 2024 to US$ 18540 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.9% during the forecast period.
Factors influencing growth in demand for farm vaccines include:
• human population growth and increasing standards of living, particularly in many emerging markets;
• increasing demand for improved nutrition, particularly animal protein;
• natural resource constraints, such as scarcity of arable land, fresh water and increased competition for cultivated land, resulting in fewer resources that will be available to meet this increased demand for animal protein;
• increasing urbanization and increased focus on food safety and food security. Rising concerns over food security and increasing animal husbandry are boosting the demand for animal vaccines for the livestock population. Increasing demand for animal products has led to growth in livestock production globally.
The primary companion animal species are dogs, cats and horses. Factors influencing growth in demand for companion animal vaccines include:
• economic development and related increases in disposable income, particularly in many emerging markets;
• increasing pet ownership
• companion animals living longer, increasing medical treatment of companion animals and advances in companion animal medicines and vaccines.

North Americas is the largest consumption place, with a consumption market share nearly 36% in 2023. Following North Americas, APAC is the second largest consumption place with the consumption market share of 30%. 
Global key Veterinary Vaccine players cover Merck, Boehringer Ingelheim, Zoetis, Elanco, Ceva, CAHIC, Jinyu Bio-Technology, HVRI, Ringpu Biology, Virbac, etc. In terms of revenue, the global five largest companies occupied for a share nearly 75.64% in 2023.
Report Includes
This report presents an overview of global market for Veterinary Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Veterinary Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Veterinary Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Veterinary Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Veterinary Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Veterinary Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio, DHN, WINSUN, etc.

Market Segmentation
By Company
    Merck
    Zoetis
    Boehringer Ingelheim
    Ceva
    CAHIC
    HVRI
    Ringpu Biology
    Yebio
    DHN
    WINSUN
    Elanco
    Virbac
    Jinyu Bio-Technology
    Medion
    CAVAC
    Kyoto Biken Laboratories
    FATRO
    Vaksindo
    Bio-Labs
    Avimex Animal Health
    MEVAC
    Biovac
    Atafen
    Dyntec
    RVSRI

Segment by Type
    Live Attenuated Vaccines
    Inactivated Vaccines
    Other

Segment by Application
    Farm Animal
    Companion Animal

Segment by region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Greece
        Ukraine
        Moldova
        Albania
        Serbia

Middle East, Africa, Latin America
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Veterinary Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
 Table 1. Global Veterinary Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Table 2. Major Manufacturers of Live Attenuated Vaccines
 Table 3. Major Manufacturers of Inactivated Vaccines
 Table 4. Major Manufacturers of Other
 Table 5. Global Veterinary Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Table 6. Global Veterinary Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 7. Global Veterinary Vaccine Revenue by Region (2019-2024) & (US$ Million)
 Table 8. Global Veterinary Vaccine Revenue by Region (2025-2030) & (US$ Million)
 Table 9. Global Veterinary Vaccine Revenue Market Share by Region (2019-2024)
 Table 10. Global Veterinary Vaccine Revenue Market Share by Region (2025-2030)
 Table 11. Global Veterinary Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (M Doses)
 Table 12. Global Veterinary Vaccine Sales by Region (2019-2024) & (M Doses)
 Table 13. Global Veterinary Vaccine Sales by Region (2025-2030) & (M Doses)
 Table 14. Global Veterinary Vaccine Sales Market Share by Region (2019-2024)
 Table 15. Global Veterinary Vaccine Sales Market Share by Region (2025-2030)
 Table 16. Global Veterinary Vaccine Sales by Manufacturers (2019-2024) & (M Doses)
 Table 17. Global Veterinary Vaccine Sales Share by Manufacturers (2019-2024)
 Table 18. Global Veterinary Vaccine Revenue by Manufacturers (2019-2024) & (US$ Million)
 Table 19. Global Veterinary Vaccine Revenue Market Share by Manufacturers (2019-2024)
 Table 20. Global Key Players of Veterinary Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
 Table 21. Veterinary Vaccine Price by Manufacturers (2019-2024) & (USD/K Doses)
 Table 22. Global Veterinary Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 23. Global Veterinary Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccine as of 2023)
 Table 24. Global Key Manufacturers of Veterinary Vaccine, Manufacturing Base Distribution and Headquarters
 Table 25. Global Key Manufacturers of Veterinary Vaccine, Product Offered and Application
 Table 26. Global Key Manufacturers of Veterinary Vaccine, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
 Table 29. Global Veterinary Vaccine Sales by Type (2025-2030) & (M Doses)
 Table 30. Global Veterinary Vaccine Sales Share by Type (2019-2024)
 Table 31. Global Veterinary Vaccine Sales Share by Type (2025-2030)
 Table 32. Global Veterinary Vaccine Revenue by Type (2019-2024) & (US$ Million)
 Table 33. Global Veterinary Vaccine Revenue by Type (2025-2030) & (US$ Million)
 Table 34. Global Veterinary Vaccine Revenue Share by Type (2019-2024)
 Table 35. Global Veterinary Vaccine Revenue Share by Type (2025-2030)
 Table 36. Veterinary Vaccine Price by Type (2019-2024) & (USD/K Doses)
 Table 37. Global Veterinary Vaccine Price Forecast by Type (2025-2030) & (USD/K Doses)
 Table 38. Global Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
 Table 39. Global Veterinary Vaccine Sales by Application (2025-2030) & (M Doses)
 Table 40. Global Veterinary Vaccine Sales Share by Application (2019-2024)
 Table 41. Global Veterinary Vaccine Sales Share by Application (2025-2030)
 Table 42. Global Veterinary Vaccine Revenue by Application (2019-2024) & (US$ Million)
 Table 43. Global Veterinary Vaccine Revenue by Application (2025-2030) & (US$ Million)
 Table 44. Global Veterinary Vaccine Revenue Share by Application (2019-2024)
 Table 45. Global Veterinary Vaccine Revenue Share by Application (2025-2030)
 Table 46. Veterinary Vaccine Price by Application (2019-2024) & (USD/K Doses)
 Table 47. Global Veterinary Vaccine Price Forecast by Application (2025-2030) & (USD/K Doses)
 Table 48. US & Canada Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
 Table 49. US & Canada Veterinary Vaccine Sales by Type (2025-2030) & (M Doses)
 Table 50. US & Canada Veterinary Vaccine Revenue by Type (2019-2024) & (US$ Million)
 Table 51. US & Canada Veterinary Vaccine Revenue by Type (2025-2030) & (US$ Million)
 Table 52. US & Canada Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
 Table 53. US & Canada Veterinary Vaccine Sales by Application (2025-2030) & (M Doses)
 Table 54. US & Canada Veterinary Vaccine Revenue by Application (2019-2024) & (US$ Million)
 Table 55. US & Canada Veterinary Vaccine Revenue by Application (2025-2030) & (US$ Million)
 Table 56. US & Canada Veterinary Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 57. US & Canada Veterinary Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 58. US & Canada Veterinary Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 59. US & Canada Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
 Table 60. US & Canada Veterinary Vaccine Sales by Country (2025-2030) & (M Doses)
 Table 61. Europe Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
 Table 62. Europe Veterinary Vaccine Sales by Type (2025-2030) & (M Doses)
 Table 63. Europe Veterinary Vaccine Revenue by Type (2019-2024) & (US$ Million)
 Table 64. Europe Veterinary Vaccine Revenue by Type (2025-2030) & (US$ Million)
 Table 65. Europe Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
 Table 66. Europe Veterinary Vaccine Sales by Application (2025-2030) & (M Doses)
 Table 67. Europe Veterinary Vaccine Revenue by Application (2019-2024) & (US$ Million)
 Table 68. Europe Veterinary Vaccine Revenue by Application (2025-2030) & (US$ Million)
 Table 69. Europe Veterinary Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 70. Europe Veterinary Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 71. Europe Veterinary Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 72. Europe Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
 Table 73. Europe Veterinary Vaccine Sales by Country (2025-2030) & (M Doses)
 Table 74. China Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
 Table 75. China Veterinary Vaccine Sales by Type (2025-2030) & (M Doses)
 Table 76. China Veterinary Vaccine Revenue by Type (2019-2024) & (US$ Million)
 Table 77. China Veterinary Vaccine Revenue by Type (2025-2030) & (US$ Million)
 Table 78. China Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
 Table 79. China Veterinary Vaccine Sales by Application (2025-2030) & (M Doses)
 Table 80. China Veterinary Vaccine Revenue by Application (2019-2024) & (US$ Million)
 Table 81. China Veterinary Vaccine Revenue by Application (2025-2030) & (US$ Million)
 Table 82. Asia Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
 Table 83. Asia Veterinary Vaccine Sales by Type (2025-2030) & (M Doses)
 Table 84. Asia Veterinary Vaccine Revenue by Type (2019-2024) & (US$ Million)
 Table 85. Asia Veterinary Vaccine Revenue by Type (2025-2030) & (US$ Million)
 Table 86. Asia Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
 Table 87. Asia Veterinary Vaccine Sales by Application (2025-2030) & (M Doses)
 Table 88. Asia Veterinary Vaccine Revenue by Application (2019-2024) & (US$ Million)
 Table 89. Asia Veterinary Vaccine Revenue by Application (2025-2030) & (US$ Million)
 Table 90. Asia Veterinary Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 91. Asia Veterinary Vaccine Revenue by Region (2019-2024) & (US$ Million)
 Table 92. Asia Veterinary Vaccine Revenue by Region (2025-2030) & (US$ Million)
 Table 93. Asia Veterinary Vaccine Sales by Region (2019-2024) & (M Doses)
 Table 94. Asia Veterinary Vaccine Sales by Region (2025-2030) & (M Doses)
 Table 95. Middle East, Africa and Latin America Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
 Table 96. Middle East, Africa and Latin America Veterinary Vaccine Sales by Type (2025-2030) & (M Doses)
 Table 97. Middle East, Africa and Latin America Veterinary Vaccine Revenue by Type (2019-2024) & (US$ Million)
 Table 98. Middle East, Africa and Latin America Veterinary Vaccine Revenue by Type (2025-2030) & (US$ Million)
 Table 99. Middle East, Africa and Latin America Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
 Table 100. Middle East, Africa and Latin America Veterinary Vaccine Sales by Application (2025-2030) & (M Doses)
 Table 101. Middle East, Africa and Latin America Veterinary Vaccine Revenue by Application (2019-2024) & (US$ Million)
 Table 102. Middle East, Africa and Latin America Veterinary Vaccine Revenue by Application (2025-2030) & (US$ Million)
 Table 103. Middle East, Africa and Latin America Veterinary Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 104. Middle East, Africa and Latin America Veterinary Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 105. Middle East, Africa and Latin America Veterinary Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 106. Middle East, Africa and Latin America Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
 Table 107. Middle East, Africa and Latin America Veterinary Vaccine Sales by Country (2025-2030) & (M Doses)
 Table 108. Merck Company Information
 Table 109. Merck Description and Major Businesses
 Table 110. Merck Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 111. Merck Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 112. Merck Recent Developments
 Table 113. Zoetis Company Information
 Table 114. Zoetis Description and Major Businesses
 Table 115. Zoetis Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 116. Zoetis Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 117. Zoetis Recent Developments
 Table 118. Boehringer Ingelheim Company Information
 Table 119. Boehringer Ingelheim Description and Major Businesses
 Table 120. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 121. Boehringer Ingelheim Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 122. Boehringer Ingelheim Recent Developments
 Table 123. Ceva Company Information
 Table 124. Ceva Description and Major Businesses
 Table 125. Ceva Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 126. Ceva Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 127. Ceva Recent Developments
 Table 128. CAHIC Company Information
 Table 129. CAHIC Description and Major Businesses
 Table 130. CAHIC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 131. CAHIC Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 132. CAHIC Recent Developments
 Table 133. HVRI Company Information
 Table 134. HVRI Description and Major Businesses
 Table 135. HVRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 136. HVRI Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 137. HVRI Recent Developments
 Table 138. Ringpu Biology Company Information
 Table 139. Ringpu Biology Description and Major Businesses
 Table 140. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 141. Ringpu Biology Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 142. Ringpu Biology Recent Developments
 Table 143. Yebio Company Information
 Table 144. Yebio Description and Major Businesses
 Table 145. Yebio Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 146. Yebio Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 147. Yebio Recent Developments
 Table 148. DHN Company Information
 Table 149. DHN Description and Major Businesses
 Table 150. DHN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 151. DHN Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 152. DHN Recent Developments
 Table 153. WINSUN Company Information
 Table 154. WINSUN Description and Major Businesses
 Table 155. WINSUN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 156. WINSUN Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 157. WINSUN Recent Developments
 Table 158. Elanco Company Information
 Table 159. Elanco Description and Major Businesses
 Table 160. Elanco Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 161. Elanco Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 162. Elanco Recent Developments
 Table 163. Virbac Company Information
 Table 164. Virbac Description and Major Businesses
 Table 165. Virbac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 166. Virbac Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 167. Virbac Recent Developments
 Table 168. Jinyu Bio-Technology Company Information
 Table 169. Jinyu Bio-Technology Description and Major Businesses
 Table 170. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 171. Jinyu Bio-Technology Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 172. Jinyu Bio-Technology Recent Developments
 Table 173. Medion Company Information
 Table 174. Medion Description and Major Businesses
 Table 175. Medion Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 176. Medion Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 177. Medion Recent Developments
 Table 178. CAVAC Company Information
 Table 179. CAVAC Description and Major Businesses
 Table 180. CAVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 181. CAVAC Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 182. CAVAC Recent Developments
 Table 183. Kyoto Biken Laboratories Company Information
 Table 184. Kyoto Biken Laboratories Description and Major Businesses
 Table 185. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 186. Kyoto Biken Laboratories Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 187. Kyoto Biken Laboratories Recent Developments
 Table 188. FATRO Company Information
 Table 189. FATRO Description and Major Businesses
 Table 190. FATRO Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 191. FATRO Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 192. FATRO Recent Developments
 Table 193. Vaksindo Company Information
 Table 194. Vaksindo Description and Major Businesses
 Table 195. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 196. Vaksindo Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 197. Vaksindo Recent Developments
 Table 198. Bio-Labs Company Information
 Table 199. Bio-Labs Description and Major Businesses
 Table 200. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 201. Bio-Labs Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 202. Bio-Labs Recent Developments
 Table 203. Avimex Animal Health Company Information
 Table 204. Avimex Animal Health Description and Major Businesses
 Table 205. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 206. Avimex Animal Health Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 207. Avimex Animal Health Recent Developments
 Table 208. MEVAC Company Information
 Table 209. MEVAC Description and Major Businesses
 Table 210. MEVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 211. MEVAC Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 212. MEVAC Recent Developments
 Table 213. Biovac Company Information
 Table 214. Biovac Description and Major Businesses
 Table 215. Biovac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 216. Biovac Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 217. Biovac Recent Developments
 Table 218. Atafen Company Information
 Table 219. Atafen Description and Major Businesses
 Table 220. Atafen Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 221. Atafen Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 222. Atafen Recent Developments
 Table 223. Dyntec Company Information
 Table 224. Dyntec Description and Major Businesses
 Table 225. Dyntec Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 226. Dyntec Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 227. Dyntec Recent Developments
 Table 228. RVSRI Company Information
 Table 229. RVSRI Description and Major Businesses
 Table 230. RVSRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 231. RVSRI Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 232. RVSRI Recent Developments
 Table 233. Key Raw Materials Lists
 Table 234. Raw Materials Key Suppliers Lists
 Table 235. Veterinary Vaccine Distributors List
 Table 236. Veterinary Vaccine Customers List
 Table 237. Veterinary Vaccine Market Trends
 Table 238. Veterinary Vaccine Market Drivers
 Table 239. Veterinary Vaccine Market Challenges
 Table 240. Veterinary Vaccine Market Restraints
 Table 241. Research Programs/Design for This Report
 Table 242. Key Data Information from Secondary Sources
 Table 243. Key Data Information from Primary Sources


List of Figures
 Figure 1. Veterinary Vaccine Product Picture
 Figure 2. Global Veterinary Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 3. Global Veterinary Vaccine Market Share by Type: 2023 & 2030
 Figure 4. Live Attenuated Vaccines Product Picture
 Figure 5. Inactivated Vaccines Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Veterinary Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 8. Global Veterinary Vaccine Market Share by Application: 2023 & 2030
 Figure 9. Farm Animal
 Figure 10. Companion Animal
 Figure 11. Veterinary Vaccine Report Years Considered
 Figure 12. Global Veterinary Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Veterinary Vaccine Revenue (2019-2030) & (US$ Million)
 Figure 14. Global Veterinary Vaccine Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Figure 15. Global Veterinary Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030
 Figure 16. Global Veterinary Vaccine Revenue Market Share by Region (2019-2030)
 Figure 17. Global Veterinary Vaccine Sales (2019-2030) & (M Doses)
 Figure 18. Global Veterinary Vaccine Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (M Doses)
 Figure 19. Global Veterinary Vaccine Sales Market Share by Region (2019-2030)
 Figure 20. US & Canada Veterinary Vaccine Sales YoY (2019-2030) & (M Doses)
 Figure 21. US & Canada Veterinary Vaccine Revenue YoY (2019-2030) & (US$ Million)
 Figure 22. Europe Veterinary Vaccine Sales YoY (2019-2030) & (M Doses)
 Figure 23. Europe Veterinary Vaccine Revenue YoY (2019-2030) & (US$ Million)
 Figure 24. China Veterinary Vaccine Sales YoY (2019-2030) & (M Doses)
 Figure 25. China Veterinary Vaccine Revenue YoY (2019-2030) & (US$ Million)
 Figure 26. Asia (excluding China) Veterinary Vaccine Sales YoY (2019-2030) & (M Doses)
 Figure 27. Asia (excluding China) Veterinary Vaccine Revenue YoY (2019-2030) & (US$ Million)
 Figure 28. Middle East, Africa and Latin America Veterinary Vaccine Sales YoY (2019-2030) & (M Doses)
 Figure 29. Middle East, Africa and Latin America Veterinary Vaccine Revenue YoY (2019-2030) & (US$ Million)
 Figure 30. Global Veterinary Vaccine Sales Share by Manufacturers (2023)
 Figure 31. The Veterinary Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
 Figure 32. Global Veterinary Vaccine Revenue Share by Manufacturers (2023)
 Figure 33. The Top 5 and 10 Largest Manufacturers of Veterinary Vaccine in the World: Market Share by Veterinary Vaccine Revenue in 2023
 Figure 34. Global Veterinary Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 35. Global Veterinary Vaccine Sales Market Share by Type (2019-2030)
 Figure 36. Global Veterinary Vaccine Revenue Market Share by Type (2019-2030)
 Figure 37. Global Veterinary Vaccine Sales Market Share by Application (2019-2030)
 Figure 38. Global Veterinary Vaccine Revenue Market Share by Application (2019-2030)
 Figure 39. US & Canada Veterinary Vaccine Sales Market Share by Type (2019-2030)
 Figure 40. US & Canada Veterinary Vaccine Revenue Market Share by Type (2019-2030)
 Figure 41. US & Canada Veterinary Vaccine Sales Market Share by Application (2019-2030)
 Figure 42. US & Canada Veterinary Vaccine Revenue Market Share by Application (2019-2030)
 Figure 43. US & Canada Veterinary Vaccine Revenue Share by Country (2019-2030)
 Figure 44. US & Canada Veterinary Vaccine Sales Share by Country (2019-2030)
 Figure 45. US Veterinary Vaccine Revenue (2019-2030) & (US$ Million)
 Figure 46. Canada Veterinary Vaccine Revenue (2019-2030) & (US$ Million)
 Figure 47. Europe Veterinary Vaccine Sales Market Share by Type (2019-2030)
 Figure 48. Europe Veterinary Vaccine Revenue Market Share by Type (2019-2030)
 Figure 49. Europe Veterinary Vaccine Sales Market Share by Application (2019-2030)
 Figure 50. Europe Veterinary Vaccine Revenue Market Share by Application (2019-2030)
 Figure 51. Europe Veterinary Vaccine Revenue Share by Country (2019-2030)
 Figure 52. Europe Veterinary Vaccine Sales Share by Country (2019-2030)
 Figure 53. Germany Veterinary Vaccine Revenue (2019-2030) & (US$ Million)
 Figure 54. France Veterinary Vaccine Revenue (2019-2030) & (US$ Million)
 Figure 55. U.K. Veterinary Vaccine Revenue (2019-2030) & (US$ Million)
 Figure 56. Italy Veterinary Vaccine Revenue (2019-2030) & (US$ Million)
 Figure 57. Russia Veterinary Vaccine Revenue (2019-2030) & (US$ Million)
 Figure 58. Greece Veterinary Vaccine Revenue (2019-2030) & (US$ Million)
 Figure 59. Ukraine Veterinary Vaccine Revenue (2019-2030) & (US$ Million)
 Figure 60. Moldova Veterinary Vaccine Revenue (2019-2030) & (US$ Million)
 Figure 61. Albania Veterinary Vaccine Revenue (2019-2030) & (US$ Million)
 Figure 62. Serbia Veterinary Vaccine Revenue (2019-2030) & (US$ Million)
 Figure 63. China Veterinary Vaccine Sales Market Share by Type (2019-2030)
 Figure 64. China Veterinary Vaccine Revenue Market Share by Type (2019-2030)
 Figure 65. China Veterinary Vaccine Sales Market Share by Application (2019-2030)
 Figure 66. China Veterinary Vaccine Revenue Market Share by Application (2019-2030)
 Figure 67. Asia Veterinary Vaccine Sales Market Share by Type (2019-2030)
 Figure 68. Asia Veterinary Vaccine Revenue Market Share by Type (2019-2030)
 Figure 69. Asia Veterinary Vaccine Sales Market Share by Application (2019-2030)
 Figure 70. Asia Veterinary Vaccine Revenue Market Share by Application (2019-2030)
 Figure 71. Asia Veterinary Vaccine Revenue Share by Region (2019-2030)
 Figure 72. Asia Veterinary Vaccine Sales Share by Region (2019-2030)
 Figure 73. Japan Veterinary Vaccine Revenue (2019-2030) & (US$ Million)
 Figure 74. South Korea Veterinary Vaccine Revenue (2019-2030) & (US$ Million)
 Figure 75. China Taiwan Veterinary Vaccine Revenue (2019-2030) & (US$ Million)
 Figure 76. Southeast Asia Veterinary Vaccine Revenue (2019-2030) & (US$ Million)
 Figure 77. India Veterinary Vaccine Revenue (2019-2030) & (US$ Million)
 Figure 78. Australia Veterinary Vaccine Revenue (2019-2030) & (US$ Million)
 Figure 79. Middle East, Africa and Latin America Veterinary Vaccine Sales Market Share by Type (2019-2030)
 Figure 80. Middle East, Africa and Latin America Veterinary Vaccine Revenue Market Share by Type (2019-2030)
 Figure 81. Middle East, Africa and Latin America Veterinary Vaccine Sales Market Share by Application (2019-2030)
 Figure 82. Middle East, Africa and Latin America Veterinary Vaccine Revenue Market Share by Application (2019-2030)
 Figure 83. Middle East, Africa and Latin America Veterinary Vaccine Revenue Share by Country (2019-2030)
 Figure 84. Middle East, Africa and Latin America Veterinary Vaccine Sales Share by Country (2019-2030)
 Figure 85. Brazil Veterinary Vaccine Revenue (2019-2030) & (US$ Million)
 Figure 86. Mexico Veterinary Vaccine Revenue (2019-2030) & (US$ Million)
 Figure 87. Turkey Veterinary Vaccine Revenue (2019-2030) & (US$ Million)
 Figure 88. Israel Veterinary Vaccine Revenue (2019-2030) & (US$ Million)
 Figure 89. GCC Countries Veterinary Vaccine Revenue (2019-2030) & (US$ Million)
 Figure 90. Veterinary Vaccine Value Chain
 Figure 91. Veterinary Vaccine Production Process
 Figure 92. Channels of Distribution (Direct Vs Distribution)
 Figure 93. Bottom-up and Top-down Approaches for This Report
 Figure 94. Data Triangulation
 Figure 95. Key Executives Interviewed